nootropics Flashcards

1
Q

how does risk of dementia change w age

A

1 in 25 of people aged 70-79, 1 in 6 people over 80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how good is current dementia treatment

A

used to treat behavioural and cognitive symptoms but has little effect on the underlying pathophysiology, targets cholinergic and serotoninergic systems, but less than 10% of patients respond to such treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what was the first nootropic

A

piracetam, showed to boost memory, learning, creativity, verbal fluency and brain circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what are the 5 nootropic principles

A

a nootropic should enhance learning and memory

should enhance the brains resistance of learned behaviours and memory to conditions that would disrupt them (such as hypoxia or electroconvulsive shock)

a nootropic should protect brain from chemical or physical assaults (such as disruption from scopalamine or barbituates)

should increase the efficacy of the tonic cortical/subcortical control mechanisms

should lack the usual pharmacology of other psychotropic durgs ( they shouldnt impair motor function or possess sedative qualities), very few side effects, low toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is a plausible mechanism for cognitive enchancers

A

they strengthen inter-synaptic communication between neurones and brain circuits that are important for learning and memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how do nootropics relate to ltp

A

repetitive activation of excitatory synapses results in long lasting increase in synaptic transmission-LTP, underlies forms of learning and memory

both in vitro studies and animal behaviour experiments suggest nootropic drugs facilitate the induction of LTP in hippocampus, leading to synapse reinforcement, which is thought to underlie memory storage and recall, can improve cognitive and memory deficits associated w dementia

associated w lowering the threshold of induction of LTP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are different classes of nootropics

A

natural; e.g caffeine

synthetic e.g modafinil, racetams

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what classes do piracetam like drugs fall under

A

cognitive enhancers: piracetam

anti epileptics

drugs w unknown clinical efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is mode of action for piracetam like cognitive enhancers

A

activation of AMPA receptor but not kainate or NMDA receptors, their effect is proposed to occur via an increase in the density of receptor binding sites and elevation of intracellular calcium levels

in 1993 croisile and others performed a study which shouwed that long term administration of piracetam could slow deterioration in patients w alzheimers, more evidence as an effective drug in patients w cognitive deterioration or stroke induced short term memory

can reduce cognition loss mediated by scopolamine perhaps via the purinergic system causing a decrease in oxadative stress and a corresponding maintenance of NTPDase and ADA levels in synaptosomes in cerebral cortex and hippocampus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what may piracetam treat

A

no significant improvement in AD

can be used in polytherapy with vasodilator cinnarizine to treat multiple sclerosis, showed improvements in activity and mood

may also be used in combination therapy in patients with the antipsychotic risperidone, results showed improvements in abnormal behaviour in patients w autistic disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is piracetams pharmacology

A

weak positive modulator of AMPA receptors, binds to S1S2 dimer interface of GluA2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

describe the antiepileptic family of piracetam like drugs

A

includes seletracetam

mechanism; inhibition of neuronal calcium ion channels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is modafinil

A

FDA approved eugeroic (promotes wakefulness) to treat narcolepsy and other sleep disorders

used as an off label cognitive enhancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is modafinils mechanism

A

produces an overall excitatory effect

proposed mechanism; increasing conc of glutamate and decreasing GABA within posterior hypothalamus

improves digit span, visual recognition memory, spatial planning

multiple effects on different brain areas and NTs

activates different circuits and brain areas compared to amphetamine and methylphenidate, while sharing inhibition of dopamine reuptake as mechanism underlying its pharmacological effects

may produce cognitive improvement in a number of neurological and psychiatric disorders with low abuse liability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how may modafinil be used in polytherapy

A

may be used as an adjunct to antipsychotics in order to ameliorate cognitive impairments in schizo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are factors of nootropic clinical trials

A

design of trial has to consider two elements:

the probability of acheiving desired change in patients cognitive function: one mehcanism is counteracting the damage caused by mental decline; can only be observed when mental decline equates to mild intellectual deterioration, early signs of dementia are often good experimental subjects, elderly patients w dementia, depression and variation in cognition arousal can be improved indirectly via improvement of patients mood and motivation making them poor subjects

the interpretation or acheivement of an observed change in the requisite cognitive task; has to be measured in a neutral environment; factors that can improve or reduce cognitive performances have to be excluded

17
Q

what are side effects of nootropics

A

armodafinils adverse effects include headache, diarrhea and nasopharyngitis

piracetams users reported symptoms of psychomotor agitation, dysphoria, tiredness, dizziness, headache and diarrhea

18
Q

what is clausenamide

A

possesses nootropic activity and enhances LTP

comes in racemic +/- form

(-) clausenamide potentiates basic synaptic transmission, potentiates high frequency stimulation induced LTP

  • form is 5-10 times more active than racemic mixture, and 50-100 times more active than piracetam
19
Q

what is the clausenamide challenge

A

10 kilograms of dried leaves produces on 3.8g of clausenamide, possible synthetic approach

20
Q

what is BRS015

A

facilitates synaptic transmission, displayes 1000 fold greater activity when compared to piracetam in identical assays

selectively potentiates AMPA/ kainate receptor mediated EPSCs but has no effect on both NMDA and kainate EPSCs

enhances glutamate evoked currents in CA3 pyramidal neurones

CC50 (cytotoxic) was found to be over 800uM, has an EC50 of 12uM